Cargando…

New Therapeutic Options for the Treatment of Sickle Cell Disease

Sickle cell disease (SCD; ORPHA232; OMIM # 603903) is a chronic and invalidating disorder distributed worldwide, with high morbidity and mortality. Given the disease complexity and the multiplicity of pathophysiological targets, development of new therapeutic options is critical, despite the positiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matte, Alessandro, Zorzi, Francesco, Mazzi, Filippo, Federti, Enrica, Olivieri, Oliviero, De Franceschi, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328043/ https://www.ncbi.nlm.nih.gov/pubmed/30671208 http://dx.doi.org/10.4084/MJHID.2019.002

Ejemplares similares

Dietary ω-3 Fatty Acid Supplementation Improves Murine Sickle Cell Bone Disease and Reprograms Adipogenesis
por: Valenti, Maria Teresa, et al.
Publicado: (2021)

Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease
por: Rossato, Paolo, et al.
Publicado: (2022)

Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease
por: Peikert, Kevin, et al.
Publicado: (2021)

In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury
por: Federti, Enrica, et al.
Publicado: (2023)

Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment
por: De Franceschi, Lucia
Publicado: (2009)

Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders
por: Tibaldi, Elena, et al.
Publicado: (2020)

Development of interactive algorithm for clinical management of acute events related to sickle cell disease in emergency department
por: Forni, Gian Luca, et al.
Publicado: (2014)

Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis
por: Federti, Enrica, et al.
Publicado: (2021)

Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out
por: De Franceschi, Lucia, et al.
Publicado: (2020)

Factor H interferes with the adhesion of sickle red cells to vascular endothelium: a novel disease-modulating molecule
por: Lombardi, Elisabetta, et al.
Publicado: (2019)

P1483: EPELEUTON, A NOVEL SYNTHETIC SECOND GENERATION W-3 FATTY ACID, PROTECTS HUMANIZED SICKLE CELL MICE AGAINST HYPOXIA/REOXYGENATION ORGAN DAMAGE
por: Federti, E., et al.
Publicado: (2022)

Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice
por: Mattè, Alessandro, et al.
Publicado: (2023)

Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury
por: De Franceschi, Lucia, et al.
Publicado: (2020)

Tyrosine Phosphorylation Modulates Peroxiredoxin-2 Activity in Normal and Diseased Red Cells
por: Mattè, Alessandro, et al.
Publicado: (2021)

P1449: SAFETY PROFILE OF KETOROLAC CONTINUOUS INFUSION IN SICKLE CELL RELATED ACUTE VASO-OCCLUSIVE CRISIS
por: Maria Pinto, Valeria, et al.
Publicado: (2023)

Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis
por: Federti, Enrica, et al.
Publicado: (2017)

Understanding Sickle cell disease: Causes, symptoms, and treatment options
por: Elendu, Chukwuka, et al.
Publicado: (2023)

Atypical hemolytic uremic syndrome: Unique clinical presentation linked to rare CFHR5 mutation
por: Menotti, Sofia, et al.
Publicado: (2021)

Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial
por: Krishnamurti, Lakshmanan, et al.
Publicado: (2019)

Duality of Nrf2 in iron-overload cardiomyopathy
por: Federti, Enrica, et al.
Publicado: (2023)

Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting
por: Pinto, Valeria Maria, et al.
Publicado: (2022)

Controlling sickle cell disease in Ghana - ethics and options
por: Kyerewaa Edwin, Ama, et al.
Publicado: (2011)

Sickle Cell Disease: Current Understanding and Future Options
por: Varelas, Christos, et al.
Publicado: (2023)

Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease?
por: Tayyaba Rehan, Syeda, et al.
Publicado: (2022)

Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis
por: Matte, Alessandro, et al.
Publicado: (2023)

Sickle Cell Disease: Management Options and Challenges in Developing Countries
por: Ansong, Daniel, et al.
Publicado: (2013)

Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
por: Tesfaye, Bekalu Amare, et al.
Publicado: (2021)

Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options
por: Panebianco, Concetta, et al.
Publicado: (2023)

Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder
por: Abruzzo, P. M., et al.
Publicado: (2019)

New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options
por: Segura, Verónica, et al.
Publicado: (2021)

Editorial: New Therapeutic Options for Rare Diseases
por: Meyer, Sascha, et al.
Publicado: (2022)

Arrhythmogenic Cardiomyopathy—Current Treatment and Future Options
por: Migliore, Federico, et al.
Publicado: (2021)

Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option
por: Maloberti, Alessandro, et al.
Publicado: (2022)

Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis
por: Peikert, Kevin, et al.
Publicado: (2021)

Clinical and epidemiological features and therapeutic options of avascular necrosis in patients with sickle cell disease (SCD): A cross-sectional study
por: Alshurafa, Awni, et al.
Publicado: (2023)

Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2022)

Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase
por: Alessandro, Matte’, et al.
Publicado: (2020)

Mesalazine in the Treatment of Extensive Alopecia Areata: A New Therapeutic Option?
por: Kiszewski, Ana Elisa, et al.
Publicado: (2018)

Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate
por: Udali, Silvia, et al.
Publicado: (2021)

Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options
por: Donnez, Jacques, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_60312l9cp734pphgnemborcrte